BACKGROUND: We have previously demonstrated that bovine dialyzable leukocyte extract (bDLE) induces death through an apoptosis mechanism in MCF-7 breast cancer cells. Depending on the cell type and stimulus, activating protein-1 (AP-1) has been shown to regulate cell proliferation and differentiation, the stress response, apoptosis and survival. It remains unknown whether AP-1 and other transcription factors are mechanisms by which bDLE induces cell death. METHODS: To determine whether bDLE modulates the AP-1 DNA binding and gene expression, MCF-7 breast cancer cells were treated with bDLE (0, 1, 5, 10 U) for 72 h and evaluated by electrophoretic mobility shift assay, reverse transcriptase-polymerase chain reaction and Western blot assays. RESULTS: bDLE induced inhibition of cell growth, suppressed the AP-1 DNA-binding activity, decreased c-Jun protein expression and modulated NFATx, NFATc, NFkappaB, c-Jun and c-Fos transcription factor gene expression in MCF-7 breast cancer cells. DISCUSSION: The present data indicate that bDLE can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells, which will have great potential in improving cancer therapy.
BACKGROUND: We have previously demonstrated that bovine dialyzable leukocyte extract (bDLE) induces death through an apoptosis mechanism in MCF-7 breast cancer cells. Depending on the cell type and stimulus, activating protein-1 (AP-1) has been shown to regulate cell proliferation and differentiation, the stress response, apoptosis and survival. It remains unknown whether AP-1 and other transcription factors are mechanisms by which bDLE induces cell death. METHODS: To determine whether bDLE modulates the AP-1 DNA binding and gene expression, MCF-7 breast cancer cells were treated with bDLE (0, 1, 5, 10 U) for 72 h and evaluated by electrophoretic mobility shift assay, reverse transcriptase-polymerase chain reaction and Western blot assays. RESULTS: bDLE induced inhibition of cell growth, suppressed the AP-1 DNA-binding activity, decreased c-Jun protein expression and modulated NFATx, NFATc, NFkappaB, c-Jun and c-Fos transcription factor gene expression in MCF-7 breast cancer cells. DISCUSSION: The present data indicate that bDLE can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells, which will have great potential in improving cancer therapy.
Authors: Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla Journal: BMC Res Notes Date: 2011-11-01
Authors: Crystel A Sierra-Rivera; Moisés A Franco-Molina; Edgar Mendoza-Gamboa; Pablo Zapata-Benavides; Jesús Santaolalla-Tapia; Erika E Coronado-Cerda; Reyes S Tamez-Guerra; Cristina Rodríguez-Padilla Journal: Oncol Lett Date: 2016-10-18 Impact factor: 2.967
Authors: Maria Del Carmen Rodríguez-Salazar; Moises Armides Franco-Molina; Edgar Mendoza-Gamboa; Ana Carolina Martínez-Torres; Pablo Zapata-Benavides; Jose Sullivan López-González; Erika Evangelina Coronado-Cerda; Juan Manuel Alcocer-González; Reyes Silvestre Tamez-Guerra; Cristina Rodríguez-Padilla Journal: Oncol Lett Date: 2017-05-18 Impact factor: 2.967
Authors: Carlos Pérez-Alvarado; Consuelo Gómez; Miguel Reyes; Mario García; Elizabeth Pérez; Carlos Pérez de la Mora; Virginia Sanchez; D Guillermo Pérez Ishiwara Journal: Biomed Res Int Date: 2017-03-12 Impact factor: 3.411
Authors: Ana Carolina Martínez-Torres; Alejandra Reyes-Ruiz; Kenny Misael Calvillo-Rodriguez; Karla Maria Alvarez-Valadez; Ashanti C Uscanga-Palomeque; Reyes S Tamez-Guerra; Cristina Rodríguez-Padilla Journal: BMC Cancer Date: 2020-07-13 Impact factor: 4.430
Authors: Luis Gomez-Morales; Alan B Martinez-Loria; Ana Carolina Martinez-Torres; Ashanti Concepcion Uscanga-Palomeque; Jose Manuel Vazquez-Guillen; Cristina Rodriguez-Padilla Journal: PeerJ Date: 2019-09-27 Impact factor: 2.984